L. Crandell Keith's Insider Trades & SAST Disclosures
L. Crandell Keith's most recent trade in Twist Bioscience Corp was a trade of 4,472 Common Stock done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern L. Crandell Keith.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 4,472 | 22,476 (0%) | 0% | 0 | Common Stock | |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 15,996 | 15,996 | - | - | Stock Option (option to buy) | |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 11,364 | 11,364 | - | - | Restricted Stock Unit | |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 7,777 | 13,927 | - | - | Common Stock | |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 7,777 | 0 | - | - | Restricted Stock Unit | |
| Twist Bioscience Corp | L. Crandell Keith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 5,815 | 18,004 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 11.16 per share. | 03 Apr 2023 | 1,170 | 131,236 (0%) | 0% | 11.2 | 13,057 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 8,212 | 12,189 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 129,051 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 12.86 per share. | 03 Jan 2023 | 1,015 | 130,066 (0%) | 0% | 12.9 | 13,053 | Common Stock |
| Quanterix Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 10.48 per share. | 03 Oct 2022 | 1,326 | 120,968 (0%) | 0% | 10.5 | 13,896 | Common Stock |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 01 Jul 2022 | 893 | 119,642 (0%) | 0% | 16.8 | 14,993 | Common Stock |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 7,970 | 7,970 | - | - | Stock Option (option to buy) | |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 4,771 | 4,771 | - | - | Restricted Stock Unit | |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,379 | 0 | - | - | Restricted Stock Unit | |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,379 | 1,379 | - | - | Common Stock, par value $0.001 | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 30.47 per share. | 01 Apr 2022 | 492 | 118,749 (0%) | 0% | 30.5 | 14,991 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 3,491 | 3,977 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 189,311 | 177,247 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 177,247 | 0 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 120,689 | 113,003 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 113,003 | 0 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 9,952 | 105,964 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 9,318 | 115,282 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,002 | 4,002 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,668 | 117,950 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 42.41 per share. | 03 Jan 2022 | 307 | 118,257 (0%) | 0% | 42.4 | 13,020 | Common Stock |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 189,311 | 366,558 (1%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 189,311 | 555,869 (1%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 120,689 | 233,692 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 120,689 | 354,381 (1%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 9,954 | 95,758 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 9,952 | 85,804 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 51.18 per share. | 01 Oct 2021 | 254 | 96,012 (0%) | 0% | 51.2 | 13,000 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 286,480 | 440,354 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 225,526 | 0 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 214,828 | 225,526 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 113,520 | 174,584 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 89,412 | 0 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 85,172 | 89,412 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Sale of securities on an exchange or to another person at price $ 106.98 per share. | 12 Aug 2021 | 41,033 | 78,602 (0%) | 0% | 107.0 | 4,389,567 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 14,560 | 97,252 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 11,462 | 119,634 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 10,918 | 108,171 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Sale of securities on an exchange or to another person at price $ 107.56 per share. | 12 Aug 2021 | 2,555 | 76,047 (0%) | 0% | 107.6 | 274,826 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director | Sale of securities on an exchange or to another person at price $ 106.93 per share. | 12 Aug 2021 | 1,412 | 486 (0%) | 0% | 106.9 | 150,985 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 1 | 108,172 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 1 | 97,253 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2021 | 1 | 119,635 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 213,740 | 745,180 (2%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 213,740 | 958,920 (3%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 213,740 | 1,172,660 (4%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 136,260 | 475,070 (1%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 136,260 | 747,590 (2%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 136,260 | 611,330 (2%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 11,237 | 64,398 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 11,237 | 53,161 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 11,236 | 75,634 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 59.48 per share. | 01 Jul 2021 | 218 | 75,852 (0%) | 0% | 59.5 | 12,967 | Common Stock |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 2,455 | 2,455 | - | - | Stock Option (option to buy) | |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,379 | 1,379 | - | - | Restricted Stock Unit | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 259,540 | 1,386,400 (4%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 259,540 | 1,645,940 (5%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 165,460 | 883,850 (3%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 165,460 | 1,049,310 (3%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 13,644 | 41,713 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 13,643 | 28,069 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 61.45 per share. | 01 Apr 2021 | 211 | 41,924 (0%) | 0% | 61.5 | 12,966 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 973 | 973 | - | - | Director Stock Option (right to buy) | |
| Twist Bioscience Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 486 | 1,898 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 2,270 | 14,229 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 44.11 per share. | 04 Jan 2021 | 197 | 14,426 (0%) | 0% | 44.1 | 8,690 | Common Stock |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | 22 Dec 2020 | 5,425,045 | 5,425,045 | - | - | Common Stock, par value $0.001 | ||
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | 22 Dec 2020 | 2,927,386 | 0 | - | - | Series A Preferred Stock | ||
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | 22 Dec 2020 | 981,443 | 0 | - | - | Series B Preferred Stock | ||
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | 22 Dec 2020 | 669,977 | 0 | - | - | Series C Preferred Stock | ||
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | 22 Dec 2020 | 665,661 | 0 | - | - | Series D Preferred Stock | ||
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 22 Dec 2020 | 300,000 | 5,725,045 | - | 20 | 6,000,000 | Common Stock, par value $0.001 |
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | 22 Dec 2020 | 180,578 | 0 | - | - | Series E Preferred Stock | ||
| 908 Devices Inc | Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 14,410 | 14,410 | - | - | Stock Option (option to buy) | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 685,613 | 1,721,809 (4%) | 1% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 497,032 | 1,224,777 (3%) | 1% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 444,231 | 780,546 (1%) | 1% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 248,083 | 706,063 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 220,641 | 485,422 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 176,030 | 309,392 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Sale of securities on an exchange or to another person at price $ 103.40 per share. | 07 Dec 2020 | 53,712 | 726,834 (1%) | 0% | 103.4 | 5,553,821 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 34,845 | 34,845 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 25,261 | 60,109 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 22,578 | 82,690 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Sale of securities on an exchange or to another person at price $ 103.40 per share. | 07 Dec 2020 | 21,288 | 288,104 (0%) | 0% | 103.4 | 2,201,179 | Common Stock |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 3 | 60,112 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 3 | 34,848 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2020 | 2 | 82,692 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2020 | 277,514 | 1,905,481 (6%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2020 | 229,006 | 2,182,995 (7%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2020 | 176,920 | 1,214,770 (4%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2020 | 145,994 | 1,391,690 (4%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2020 | 1,034 | 11,959 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges